Oxford Nanopore Technologies Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
1,314
- Stock Symbol
-
ONT
- Investments
-
3
- Share Price
-
$2.67
- (As of Thursday Closing)
Oxford Nanopore Technologies General Information
Description
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
Contact Information
Website
www.nanoporetech.comCorporate Office
- Gosling Building
- Edmund Halley Road, Oxford Science Park
- Oxford OX4 4DQ
- England, United Kingdom
Corporate Office
- Gosling Building
- Edmund Halley Road, Oxford Science Park
- Oxford OX4 4DQ
- England, United Kingdom
Oxford Nanopore Technologies Timeline
Oxford Nanopore Technologies Stock Performance
As of 12-Nov-2026, Oxford Nanopore Technologies’s stock price is $2.67. Its current market cap is $2.62B with 981M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.67 | $2.74 | $1.28 - $3.19 | $2.62B | 981M | 3.19M | -$0.17 |
Oxford Nanopore Technologies Financials Summary
As of 30-Jun-2026, Oxford Nanopore Technologies has a trailing 12-month revenue of $315M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,316,766 | 1,282,584 | 1,276,969 | 1,839,975 |
| Revenue | 315,326 | 294,923 | 234,080 | 210,904 |
| EBITDA | (90,707) | (130,536) | (137,867) | (155,116) |
| Net Income | (162,896) | (191,259) | (186,804) | (192,058) |
| Total Assets | 749,321 | 838,248 | 931,050 | 989,901 |
| Total Debt | 55,397 | 55,883 | 57,720 | 53,064 |
Oxford Nanopore Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oxford Nanopore Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Oxford Nanopore Technologies Comparisons
Industry
Financing
Details
Oxford Nanopore Technologies Competitors (29)
One of Oxford Nanopore Technologies’s 29 competitors is Pacific BioSciences of California, a Formerly VC-backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pacific BioSciences of California | Formerly VC-backed | Menlo Park, CA | ||||
| Quantapore | Venture Capital-Backed | South San Francisco, CA | ||||
| OncoDNA | Venture Capital-Backed | Gosselies, Belgium | ||||
| Vizgen | Venture Capital-Backed | Cambridge, MA | ||||
| Illumina | Formerly VC-backed | San Diego, CA |
Oxford Nanopore Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oxford Nanopore Technologies Patents
Oxford Nanopore Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202509766-D0 | A nanopore array support structure | Pending | 19-Jun-2025 | ||
| GB-202509757-D0 | A nanopore sensor device | Pending | 19-Jun-2025 | ||
| GB-202509723-D0 | Method | Pending | 19-Jun-2025 | ||
| GB-202509661-D0 | A nanopore sensor device | Pending | 18-Jun-2025 | ||
| GB-202508222-D0 | A level shifting circuit, an ewod sample preperation device, and methods of operating the same | Pending | 27-May-2025 | H03K19/018521 |
Oxford Nanopore Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oxford Nanopore Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Oxford Nanopore Technologies Investments & Acquisitions (3)
Oxford Nanopore Technologies’s most recent deal was a Merger/Acquisition with Northern Nanopore Instruments. The deal was made on 03-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Northern Nanopore Instruments | 03-Nov-2023 | Merger/Acquisition | Electronic Equipment and Instruments | ||
| Veiovia | 09-Dec-2021 | Early Stage VC | Media and Information Services (B2B) | ||
| Veiovia | 28-Sep-2020 | Seed Round | Media and Information Services (B2B) |
Oxford Nanopore Technologies ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
21.62 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Oxford Nanopore Technologies Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Oxford Nanopore Technologies Denmark | Hellerup, Denmark | 2020 | |
| Northern Nanopore Instruments | Ottawa, Canada | 2020 |
Oxford Nanopore Technologies FAQs
-
When was Oxford Nanopore Technologies founded?
Oxford Nanopore Technologies was founded in 2005.
-
Where is Oxford Nanopore Technologies headquartered?
Oxford Nanopore Technologies is headquartered in Oxford, United Kingdom.
-
What is the size of Oxford Nanopore Technologies?
Oxford Nanopore Technologies has 1,314 total employees.
-
What industry is Oxford Nanopore Technologies in?
Oxford Nanopore Technologies’s primary industry is Biotechnology.
-
Is Oxford Nanopore Technologies a private or public company?
Oxford Nanopore Technologies is a Public company.
-
What is Oxford Nanopore Technologies’s stock symbol?
The ticker symbol for Oxford Nanopore Technologies is ONT.
-
What is the current stock price of Oxford Nanopore Technologies?
As of 12-Nov-2026 the stock price of Oxford Nanopore Technologies is $2.67.
-
What is the current market cap of Oxford Nanopore Technologies?
The current market capitalization of Oxford Nanopore Technologies is $2.62B.
-
What is Oxford Nanopore Technologies’s current revenue?
The trailing twelve month revenue for Oxford Nanopore Technologies is $315M.
-
Who are Oxford Nanopore Technologies’s competitors?
Pacific BioSciences of California, Quantapore, OncoDNA, Vizgen, and Illumina are some of the 29 competitors of Oxford Nanopore Technologies.
-
What is Oxford Nanopore Technologies’s annual earnings per share (EPS)?
Oxford Nanopore Technologies’s EPS for 12 months was -$0.17.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
